These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25512261)

  • 1. Electrochemical and mARC-catalyzed enzymatic reduction of para-substituted benzamidoximes: consequences for the prodrug concept "amidoximes instead of amidines".
    Bauch E; Reichmann D; Mendel RR; Bittner F; Manke AM; Kurz P; Girreser U; Havemeyer A; Clement B
    ChemMedChem; 2015 Feb; 10(2):360-7. PubMed ID: 25512261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs.
    Gruenewald S; Wahl B; Bittner F; Hungeling H; Kanzow S; Kotthaus J; Schwering U; Mendel RR; Clement B
    J Med Chem; 2008 Dec; 51(24):8173-7. PubMed ID: 19053771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of L-valine-amidoximeesters as double prodrugs of amidines.
    Kotthaus J; Hungeling H; Reeh C; Kotthaus J; Schade D; Wein S; Wolffram S; Clement B
    Bioorg Med Chem; 2011 Mar; 19(6):1907-14. PubMed ID: 21345682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of N-hydroxy-sulfonamides, including N-hydroxy-valdecoxib, by the molybdenum-containing enzyme mARC.
    Havemeyer A; Grünewald S; Wahl B; Bittner F; Mendel R; Erdélyi P; Fischer J; Clement B
    Drug Metab Dispos; 2010 Nov; 38(11):1917-21. PubMed ID: 20699408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid).
    Clement B; Mau S; Deters S; Havemeyer A
    Drug Metab Dispos; 2005 Nov; 33(11):1740-7. PubMed ID: 16118330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme.
    Havemeyer A; Bittner F; Wollers S; Mendel R; Kunze T; Clement B
    J Biol Chem; 2006 Nov; 281(46):34796-802. PubMed ID: 16973608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC).
    Ott G; Plitzko B; Krischkowski C; Reichmann D; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A
    Chem Res Toxicol; 2014 Oct; 27(10):1687-95. PubMed ID: 25170804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fourth mammalian molybdenum enzyme mARC: current state of research.
    Havemeyer A; Lang J; Clement B
    Drug Metab Rev; 2011 Nov; 43(4):524-39. PubMed ID: 21942410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of in vitro biotransformation of new, orally active, direct thrombin inhibitor ximelagatran, an amidoxime and ester prodrug.
    Clement B; Lopian K
    Drug Metab Dispos; 2003 May; 31(5):645-51. PubMed ID: 12695354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N,N'-dihydroxyamidines: a new prodrug principle to improve the oral bioavailability of amidines.
    Reeh C; Wundt J; Clement B
    J Med Chem; 2007 Dec; 50(26):6730-4. PubMed ID: 18052320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of N-hydroxylated compounds: amidoximes (N-hydroxyamidines) as pro-drugs of amidines.
    Clement B
    Drug Metab Rev; 2002 Aug; 34(3):565-79. PubMed ID: 12214667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5 in N-reductive metabolism in human cells.
    Plitzko B; Ott G; Reichmann D; Henderson CJ; Wolf CR; Mendel R; Bittner F; Clement B; Havemeyer A
    J Biol Chem; 2013 Jul; 288(28):20228-37. PubMed ID: 23703616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and partial purification of the rat and human enzyme systems active in the reduction of N-hydroxymelagatran and benzamidoxime.
    Andersson S; Hofmann Y; Nordling A; Li XQ; Nivelius S; Andersson TB; Ingelman-Sundberg M; Johansson I
    Drug Metab Dispos; 2005 Apr; 33(4):570-8. PubMed ID: 15640373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Involvement of the Mitochondrial Amidoxime Reducing Component (mARC) in the Reductive Metabolism of Hydroxamic Acids.
    Ginsel C; Plitzko B; Froriep D; Stolfa DA; Jung M; Kubitza C; Scheidig AJ; Havemeyer A; Clement B
    Drug Metab Dispos; 2018 Oct; 46(10):1396-1402. PubMed ID: 30045842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of highly potent amidine containing inhibitors of serine proteases and their N-hydroxylated prodrugs (amidoximes).
    Kotthaus J; Steinmetzer T; van de Locht A; Clement B
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):115-22. PubMed ID: 20583861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the anti-cancer agent upamostat by the mARC enzyme system.
    Froriep D; Clement B; Bittner F; Mendel RR; Reichmann D; Schmalix W; Havemeyer A
    Xenobiotica; 2013 Sep; 43(9):780-4. PubMed ID: 23379481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the microsomal N-hydroxylation of para-substituted benzamidines.
    Clement B; Zimmermann M
    Biochem Pharmacol; 1988 Dec; 37(24):4747-52. PubMed ID: 3202907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice.
    Jakobs HH; Mikula M; Havemeyer A; Strzalkowska A; Borowa-Chmielak M; Dzwonek A; Gajewska M; Hennig EE; Ostrowski J; Clement B
    PLoS One; 2014; 9(8):e105371. PubMed ID: 25144769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-substituted bis-C-alkyloxadiazolones as dual effectors: efficient intermediates to amidoximes or amidines and prodrug candidates of potent antimalarials.
    Degardin M; Wein S; Durand T; Escale R; Vial H; Vo-Hoang Y
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5233-6. PubMed ID: 19643611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detoxification of Trimethylamine N-Oxide by the Mitochondrial Amidoxime Reducing Component mARC.
    Schneider J; Girreser U; Havemeyer A; Bittner F; Clement B
    Chem Res Toxicol; 2018 Jun; 31(6):447-453. PubMed ID: 29856598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.